with CoQ10 spray application

PreclinicalSmall molecule

with CoQ10 spray application is one of 3 small molecule programs targeting Gingival Recession. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Gingival RecessionCompleted

Gingival RecessionPreclinical

Completed

Competition

Competitive Landscape

2 competitors in Gingival Recession

#DrugCompanyPhaseTrials

Sodium Dipyrone

UUniversidade Estadual Paulista Júlio de Mesquita Filho

Preclinical

4 2

Chlorhexidine Rinse

UUniversidade Estadual Paulista Júlio de Mesquita Filho

Preclinical

2 3

with CoQ10 spray application

UUniversity of Bern

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Gingival Recession1 trial

Ubiquinone (Coenzyme Q10) Application After Gingival Recession Coverage

Completed·UUniversity of Bern·N/A·NCT04487652·30 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for with CoQ10 spray application. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — with CoQ10 spray application compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for with CoQ10 spray application. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Bern company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: UUniversity of Bern

with CoQ10 spray application

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Gingival Recession1 trial

References

Drug Info

Quick Facts

Related News